CRISPR Therapeutics AG Cash and Cash Equivalents 2011-2026 | CRSP

Annual Cash and Cash Equivalents CRISPR Therapeutics AG

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
348 M	298 M	389 M	212 M	923 M	1.17 B	944 M	457 M	240 M	316 M	156 M	945 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.17 B	945 K	454 M

Quarterly Cash and Cash Equivalents CRISPR Therapeutics AG

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
286 M	194 M	235 M	298 M	226 M	484 M	707 M	389 M	528 M	445 M	344 M	212 M	494 M	497 M	684 M	923 M	1.01 B	1.65 B	1.13 B	1.17 B	1.17 B	1.17 B	1.17 B	944 M	944 M	944 M	944 M	457 M	457 M	457 M	457 M	240 M	254 M	272 M	289 M	316 M	316 M	316 M	316 M	156 M	156 M	-	-	945 K	-	-	-	361 K	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.65 B	361 K	550 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	61.6 M	-	1052.0 %	$ 415 M	USA
Autolus Therapeutics plc AUTL	240 M	$ 1.68	2.44 %	$ 429 M	Britain
Acer Therapeutics ACER	2.33 M	-	2.71 %	$ 14 M	USA
Acasti Pharma ACST	22.1 M	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	60.7 M	-	-	$ 86.2 M	USA
Kamada Ltd. KMDA	78.4 M	$ 8.81	1.73 %	$ 260 M	Israel
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Adagene ADAG	75.2 M	$ 3.26	0.62 %	$ 183 M	China
Alterity Therapeutics Limited ATHE	34.8 M	$ 3.28	-2.62 %	$ 7.89 B	Australia
Evogene Ltd. EVGN	15.3 M	$ 0.81	-9.28 %	$ 27.9 M	Israel
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Nymox Pharmaceutical Corporation NYMX	830 K	-	-19.68 %	$ 18.4 M	Canada
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
Aptorum Group Limited APM	3.5 M	$ 0.79	-1.29 %	$ 4.31 M	China
Alpine Immune Sciences ALPN	13.4 M	-	-	$ 2.17 B	USA
AlloVir ALVR	118 M	-	4.14 %	$ 49.1 M	USA
XTL Biopharmaceuticals Ltd. XTLB	371 K	$ 0.88	-1.43 %	$ 442 M	Israel
Allena Pharmaceuticals ALNA	30 M	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
Aptose Biosciences APTO	6.15 M	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA
Ascendis Pharma A/S ASND	616 M	$ 224.42	-2.52 %	$ 5 B	Danmark
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Arena Pharmaceuticals ARNA	220 M	-	-6.81 %	$ 3.04 B	USA
Athersys ATHX	37.4 M	-	3.77 %	$ 22.4 M	USA
AVROBIO AVRO	98 M	-	1083.1 %	$ 745 M	USA
Anavex Life Sciences Corp. AVXL	103 M	$ 4.13	0.12 %	$ 352 M	USA
Aeterna Zentaris AEZS	16.4 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	345 K	-	-10.17 %	$ 12.2 K	USA
Aytu BioScience AYTU	31 M	$ 2.36	2.27 %	$ 14.8 M	USA
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
AstraZeneca PLC AZN	5.49 B	-	-	$ 96.9 B	Britain
Aridis Pharmaceuticals ARDS	4.88 M	-	17.91 %	$ 11.1 M	USA
Brickell Biotech BBI	10.9 M	-	-5.38 %	$ 6.06 M	USA
Codexis CDXS	19.3 M	$ 1.17	-0.85 %	$ 85.9 M	USA
Athira Pharma ATHA	48.4 M	-	-	$ 269 M	USA
BioNTech SE BNTX	9.76 B	$ 110.12	-0.28 %	$ 27.2 B	Germany
Amneal Pharmaceuticals AMRX	111 M	$ 14.49	-0.75 %	$ 4.48 B	USA
AIkido Pharma AIKI	4.08 M	-	1.93 %	$ 17.4 M	USA
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany